Caribou Biosciences (CRBU) Assets Average (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Assets Average data on file, last reported at $162.2 million in Q1 2026.

• Assets Average for Q1 2026 came in at $162.2 million, down 44.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $162.2 million (down 44.74% YoY), and the FY2025 annual result was $244.3 million, down 34.45% from the prior year.
• Assets Average fell to $162.2 million in Q1 2026 per CRBU's latest filing, from $185.2 million in the prior quarter.
• Over five years, Assets Average peaked at $444.9 million in Q4 2023 and troughed at $162.2 million in Q1 2026.
• A 5-year average of $342.6 million and a median of $360.6 million in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2026: Assets Average jumped 32.21% in 2022, then slumped 44.74% in 2026.
• A 5-year view of Assets Average shows it stood at $386.3 million in 2022, then advanced by 15.16% to $444.9 million in 2023, then slipped by 26.08% to $328.8 million in 2024, then tumbled by 43.69% to $185.2 million in 2025, then fell by 12.42% to $162.2 million in 2026.
• Business Quant data shows CRBU's Assets Average at $162.2 million in Q1 2026, $185.2 million in Q4 2025, and $207.9 million in Q3 2025.